Multicenter study reveals alarming terbinafine resistance in Trichophyton indotineae isolates from Iran.

IF 3.5 3区 医学 Q3 INFECTIOUS DISEASES
Shima Aboutalebian, Zahra Jahanshiri, Mahboobeh Kharazi, Mohammad Reza Shidfar, Shahla Shadzi, Mostafa Chadeganipour, Mahzad Erami, Hossein Mirhendi
{"title":"Multicenter study reveals alarming terbinafine resistance in Trichophyton indotineae isolates from Iran.","authors":"Shima Aboutalebian, Zahra Jahanshiri, Mahboobeh Kharazi, Mohammad Reza Shidfar, Shahla Shadzi, Mostafa Chadeganipour, Mahzad Erami, Hossein Mirhendi","doi":"10.1093/mmy/myag064","DOIUrl":null,"url":null,"abstract":"<p><p>Trichophyton indotineae has recently emerged as a major etiological agent of treatment-resistant dermatophytosis, particularly in India and Iran. Resistance to terbinafine is predominantly associated with point mutations in the squalene epoxidase (SQLE) gene. This study investigated the antifungal susceptibility of clinical dermatophyte isolates from Iran and characterized SQLE mutations in terbinafine-resistant strains. Over a 6-month period, 176 clinical dermatophyte isolates comprising 134 T. indotineae and 42 non-indotineae species were collected and identified by internal transcribed spacer (ITS) sequencing. In vitro antifungal susceptibility testing to eight antifungal agents was assessed according to CLSI M38 guidelines. Minimum inhibitory concentration (MIC) ranges, MIC₅₀, MIC₉₀, and geometric mean MICs were calculated. SQLE gene sequencing was performed for isolates exhibiting reduced terbinafine susceptibility. Out of 176 dermatophyte isolates, 66 (37.5%) demonstrated terbinafine MICs ≥ 0.5 µg/ml. Among these 66 isolates, 64 were T. indotineae (out of 134 total T. indotineae isolates, 47.76%), and 2 were T. tonsurans (out of 21 total T. tonsurans isolates, 9.52%). High-level terbinafine resistance (MIC ≥ 16 µg/ml) was observed in 50% (32/64) of T. indotineae isolates. Among the 66 resistant isolates, only 3 were wild-type: one T. indotineae and two T. tonsurans. The most prevalent SQLE alterations were the double mutation Phe397Leu + Ala448Thr (34.38%) and the single mutation Leu393Ser (32.81%), followed by the 1192 C→A substitution (10.94%). Notably, Ala448Thr also occurred in phenotypically susceptible isolates, yet correlated with increased MICs of itraconazole and voriconazole. Fluconazole showed poor activity (geometric mean MIC: 43.5072 µg/ml), whereas posaconazole exhibited the highest in vitro activity. Terbinafine remained effective for non-T. indotineae species, but is ineffective for T. indotineae-associated dermatophytosis due to widespread resistance. None of the isolates identified as T. interdigitale/mentagrophytes, T. rubrum, Microsporum canis, and Trichophyton benhamiae were resistant to TRB. This multicenter survey reveals high terbinafine resistance in Iranian T. indotineae isolates, linked to SQLE mutations and azole cross-resistance. Routine antifungal susceptibility testing, molecular screening, and alternative therapies are essential, prioritizing non-terbinafine options for T. indotineae (while it remains effective against other dermatophytes). Continued surveillance, accurate species identification, and tailored management are critical to control recalcitrant dermatophytosis.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myag064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Trichophyton indotineae has recently emerged as a major etiological agent of treatment-resistant dermatophytosis, particularly in India and Iran. Resistance to terbinafine is predominantly associated with point mutations in the squalene epoxidase (SQLE) gene. This study investigated the antifungal susceptibility of clinical dermatophyte isolates from Iran and characterized SQLE mutations in terbinafine-resistant strains. Over a 6-month period, 176 clinical dermatophyte isolates comprising 134 T. indotineae and 42 non-indotineae species were collected and identified by internal transcribed spacer (ITS) sequencing. In vitro antifungal susceptibility testing to eight antifungal agents was assessed according to CLSI M38 guidelines. Minimum inhibitory concentration (MIC) ranges, MIC₅₀, MIC₉₀, and geometric mean MICs were calculated. SQLE gene sequencing was performed for isolates exhibiting reduced terbinafine susceptibility. Out of 176 dermatophyte isolates, 66 (37.5%) demonstrated terbinafine MICs ≥ 0.5 µg/ml. Among these 66 isolates, 64 were T. indotineae (out of 134 total T. indotineae isolates, 47.76%), and 2 were T. tonsurans (out of 21 total T. tonsurans isolates, 9.52%). High-level terbinafine resistance (MIC ≥ 16 µg/ml) was observed in 50% (32/64) of T. indotineae isolates. Among the 66 resistant isolates, only 3 were wild-type: one T. indotineae and two T. tonsurans. The most prevalent SQLE alterations were the double mutation Phe397Leu + Ala448Thr (34.38%) and the single mutation Leu393Ser (32.81%), followed by the 1192 C→A substitution (10.94%). Notably, Ala448Thr also occurred in phenotypically susceptible isolates, yet correlated with increased MICs of itraconazole and voriconazole. Fluconazole showed poor activity (geometric mean MIC: 43.5072 µg/ml), whereas posaconazole exhibited the highest in vitro activity. Terbinafine remained effective for non-T. indotineae species, but is ineffective for T. indotineae-associated dermatophytosis due to widespread resistance. None of the isolates identified as T. interdigitale/mentagrophytes, T. rubrum, Microsporum canis, and Trichophyton benhamiae were resistant to TRB. This multicenter survey reveals high terbinafine resistance in Iranian T. indotineae isolates, linked to SQLE mutations and azole cross-resistance. Routine antifungal susceptibility testing, molecular screening, and alternative therapies are essential, prioritizing non-terbinafine options for T. indotineae (while it remains effective against other dermatophytes). Continued surveillance, accurate species identification, and tailored management are critical to control recalcitrant dermatophytosis.

多中心研究显示伊朗印多毛癣菌对特比萘芬的耐药性令人担忧。
印度毛癣菌最近已成为难治性皮肤病的主要病原,特别是在印度和伊朗。对特比萘芬的抗性主要与角鲨烯环氧化酶(SQLE)基因的点突变有关。本研究调查了伊朗临床皮肤真菌分离株的抗真菌敏感性,并鉴定了特比萘芬耐药菌株的SQLE突变。在6个月的时间里,收集了176株临床分离的皮癣菌,其中134株为indotineae, 42株为非indotineae,并通过ITS测序对其进行了鉴定。根据CLSI M38指南评估8种抗真菌药物的体外抗真菌药敏试验。计算了MIC范围,MIC₅0,MIC₉0和几何平均MIC。对特比萘芬敏感性降低的分离株进行SQLE基因测序。在176株皮肤真菌分离株中,66株(37.5%)的特比萘芬mic≥0.5µg/mL。66株分离株中,印蚊64株(134株印蚊分离株中占47.76%),疣体2株(21株印蚊分离株中占9.52%)。50%(32/64)的indotineae分离株对特比萘芬有高水平耐药性(MIC≥16µg/mL)。在66株耐药菌株中,只有3株为野生型:1株为indottineae, 2株为tonsurans。最常见的SQLE突变是双突变Phe397Leu + Ala448Thr(34.38%)和单突变Leu393Ser(32.81%),其次是1192 C→A取代(10.94%)。值得注意的是,Ala448Thr也出现在表型敏感的分离株中,但与伊曲康唑和伏立康唑的mic升高相关。氟康唑的活性较差(几何平均MIC为43.5072µg/mL),泊沙康唑的活性最高。特比萘芬对非t有效。但由于广泛的抗性,对与吲哚吲哚菌相关的皮肤真菌病无效。经鉴定为双指/多植T.、rubrum T.、犬小孢子菌(Microsporum canis)和benhami毛癣菌(Trichophyton benhamiae)的菌株对TRB均无抗性。这项多中心调查显示,伊朗印蚊分离株对特比萘芬具有高耐药性,与SQLE突变和唑交叉耐药有关。常规的抗真菌药敏试验,分子筛选和替代疗法是必不可少的,优先考虑非特比萘芬对印多啶t的选择(同时它对其他皮肤真菌仍然有效)。持续的监测,准确的物种鉴定和量身定制的管理是控制顽固性皮肤真菌病的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical mycology
Medical mycology 医学-兽医学
CiteScore
5.70
自引率
3.40%
发文量
632
审稿时长
12 months
期刊介绍: Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书